|
EI24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.42049999996008E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.447100E-04 |
| Normal-vs-Stage2 |
9.86610000031085E-07 |
| Normal-vs-Stage3 |
2.16419999999884E-05 |
| Normal-vs-Stage4 |
3.73670000000104E-05 |
| Stage1-vs-Stage2 |
1.764050E-02 |
| Stage1-vs-Stage3 |
8.676000E-02 |
| Stage1-vs-Stage4 |
6.481600E-02 |
| Stage2-vs-Stage3 |
3.287400E-01 |
| Stage2-vs-Stage4 |
5.414400E-01 |
| Stage3-vs-Stage4 |
7.717800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51949999996448E-06 |
| Normal-vs-AfricanAmerican |
2.027500E-04 |
| Normal-vs-Asian |
2.356500E-02 |
| Caucasian-vs-AfricanAmerican |
7.317600E-01 |
| Caucasian-vs-Asian |
5.209400E-01 |
| AfricanAmerican-vs-Asian |
5.812000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.72449999519864E-08 |
| Normal-vs-Female |
2.359000E-03 |
| Male-vs-Female |
2.935100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.579800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.36300000000522E-06 |
| Normal-vs-Age(61-80Yrs) |
4.17480000000081E-05 |
| Normal-vs-Age(81-100Yrs) |
3.213700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.231600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.532400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.804200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.319400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.273200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.891800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.956200E-01 |
| Normal-vs-Grade 2 |
3.801500E-04 |
| Normal-vs-Grade 3 |
1.98209999968668E-07 |
| Normal-vs-Grade 4 |
3.90900000000194E-05 |
| Grade 1-vs-Grade 2 |
2.906600E-01 |
| Grade 1-vs-Grade 3 |
5.571500E-02 |
| Grade 1-vs-Grade 4 |
7.570000E-02 |
| Grade 2-vs-Grade 3 |
2.177400E-03 |
| Grade 2-vs-Grade 4 |
5.006000E-02 |
| Grade 3-vs-Grade 4 |
7.135800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.001300E-03 |
| Normal-vs-ccB subtype |
2.40679999996551E-06 |
| ccA subtype-vs-ccB subtype |
3.063500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.9666000000983E-07 |
| Normal-vs-N1 |
5.283000E-03 |
| N0-vs-N1 |
5.327600E-01 |
|
|
